Clinical Trial Update: Ketamine Biomarker Validation [Phase 1]

View source ↗

Summary

A Phase 1 trial from Soterix Medical is validating ketamine biomarkers for treatment-resistant depression and is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Treatment-resistant Depression

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: Soterix Medical | Conditions: Treatment Resistant Depression (TRD) | Phase 1 | Status: NOT_YET_RECRUITING